Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 70.16% is 15% above its 5-year average of 61.13%, near the high end of its 5-year range (54.60%–72.92%).
0.66% below its 12-month average of 70.63%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
70.16%
GROSS MARGIN AVG TTM
70.63%
GROSS MARGIN AVG 3Y
63.16%
GROSS MARGIN AVG 5Y
61.13%
GROSS MARGIN AVG 10Y
63.37%
GROSS MARGIN AVG 15Y
66.95%
GROSS MARGIN AVG 20Y
67.74%
CURRENT VS TTM AVG
-0.66%
CURRENT VS 3Y AVG
+11.09%
CURRENT VS 5Y AVG
+14.78%
CURRENT VS 10Y AVG
+10.72%
CURRENT VS 15Y AVG
+4.79%
CURRENT VS 20Y AVG
+3.58%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+18.93%
vs the sector median at left
Bristol-Myers Squibb Company
Market Cap
$132.14B
Gross Margin
70.16%
TTM Avg
70.63%
3Y Avg
63.16%
5Y Avg
61.13%
Market Cap
$134.24B
Gross Margin
86.04%
TTM Avg
85.57%
3Y Avg
86.56%
5Y Avg
87.08%
Market Cap
$123.70B
Gross Margin
66.68%
TTM Avg
66.73%
3Y Avg
66.82%
5Y Avg
67.04%
Market Cap
$144.25B
Gross Margin
58.51%
TTM Avg
60.22%
3Y Avg
59.98%
5Y Avg
59.48%
Market Cap
$105.97B
Gross Margin
65.17%
TTM Avg
62.91%
3Y Avg
61.66%
5Y Avg
61.70%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Company (BMY) | $132.14B | 70.16% | 70.63% | 63.16% | 61.13% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.24B | 86.04% | 85.57% | 86.56% | 87.08% |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.70B | 66.68% | 66.73% | 66.82% | 67.04% |
| CVS Health Corp. (CVS)vs › | $122.58B | 14.15% | 13.78% | 14.92% | 15.96% |
| Danaher Corporation (DHR)vs › | $144.25B | 58.51% | 60.22% | 59.98% | 59.48% |
| Medtronic plc (MDT)vs › | $118.26B | 66.69% | 65.17% | 65.34% | 65.75% |
| Stryker Corporation (SYK)vs › | $105.97B | 65.17% | 62.91% | 61.66% | 61.70% |
| Pfizer Inc. (PFE)vs › | $158.39B | 71.32% | 68.05% | 62.23% | 63.06% |
| McKesson Corporation (MCK)vs › | $104.10B | 3.64% | 3.54% | 3.83% | 4.16% |
| Sanofi (SNY)vs › | $103.62B | 73.01% | 71.13% | 70.66% | 69.80% |
Gross Margin
70.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 71.28% |
| 2026-03-31 | 70.22% |
| 2025-12-31 | 67.23% |
| 2025-09-30 | 71.89% |
| 2025-06-30 | 72.52% |
| 2025-03-31 | 72.92% |
| 2024-12-31 | 60.15% |
| 2024-09-30 | 55.64% |
| 2024-06-30 | 55.74% |
| 2024-03-31 | 55.54% |
| 2023-12-31 | 56.57% |
| 2023-09-30 | 56.72% |
| 2023-06-30 | 54.60% |
| 2023-03-31 | 57.48% |
| 2022-12-31 | 56.90% |
| 2022-09-30 | 57.47% |
| 2022-06-30 | 57.15% |
| 2022-03-31 | 58.04% |
| 2021-12-31 | 60.02% |
| 2021-09-30 | 58.23% |
| 2021-06-30 | 57.34% |
| 2021-03-31 | 54.98% |
| 2020-12-31 | 56.37% |
| 2020-09-30 | 52.77% |
| 2020-06-30 | 49.85% |
| 2020-03-31 | 44.99% |
| 2019-12-31 | 55.57% |
| 2019-09-30 | 70.23% |
| 2019-06-30 | 70.19% |
| 2019-03-31 | 69.05% |
| 2018-12-31 | 71.74% |
| 2018-09-30 | 71.02% |
| 2018-06-30 | 71.98% |
| 2018-03-31 | 69.36% |
| 2017-12-31 | 68.93% |
| 2017-09-30 | 70.23% |
| 2017-06-30 | 73.04% |
| 2017-03-31 | 75.27% |
| 2016-12-31 | 70.04% |
| 2016-09-30 | 73.49% |
| 2016-06-30 | 75.24% |
| 2016-03-31 | 76.04% |
| 2015-12-31 | 77.79% |
| 2015-09-30 | 73.04% |
| 2015-06-30 | 75.67% |
| 2015-03-31 | 79.04% |
| 2014-12-31 | 77.31% |
| 2014-09-30 | 74.32% |
| 2014-06-30 | 74.52% |
| 2014-03-31 | 74.60% |
| 2013-12-31 | 71.34% |
| 2013-09-30 | 71.09% |
| 2013-06-30 | 72.63% |
| 2013-03-31 | 72.25% |
| 2012-12-31 | 74.35% |
| 2012-09-30 | 73.58% |
| 2012-06-30 | 71.98% |
| 2012-03-31 | 75.19% |
| 2011-12-31 | 74.94% |
| 2011-09-30 | 73.68% |
| 2011-06-30 | 72.75% |
| 2011-03-31 | 73.20% |
| 2010-12-31 | 72.33% |
| 2010-09-30 | 73.32% |
| 2010-06-30 | 73.22% |
| 2010-03-31 | 72.83% |
| 2009-12-31 | 75.91% |
| 2009-09-30 | 71.53% |
| 2009-06-30 | 72.86% |
| 2009-03-31 | 71.82% |
| 2008-12-31 | 71.00% |
| 2008-09-30 | 68.90% |
| 2008-06-30 | 67.90% |
| 2008-03-31 | 68.02% |
| 2007-12-31 | 66.18% |
| 2007-09-30 | 67.88% |
| 2007-06-30 | 68.57% |
| 2007-03-31 | 68.90% |
| 2006-12-31 | 65.65% |
| 2006-09-30 | 64.73% |
| 2006-06-30 | 67.81% |
| 2006-03-31 | 68.43% |
| 2005-12-31 | 68.22% |
| 2005-09-30 | 68.89% |
| 2005-06-30 | 69.67% |
| 2005-03-31 | 69.84% |
| 2004-12-31 | 103.14% |
| 2004-09-30 | 61.30% |
| 2004-06-30 | 61.42% |
| 2004-03-31 | 63.35% |
| 2003-12-31 | 61.98% |
| 2003-09-30 | 64.25% |
| 2003-06-30 | 64.45% |
| 2003-03-31 | 64.23% |
| 2002-12-31 | 63.16% |
| 2002-09-30 | 63.54% |
